stroke and brain injury, Completed Research

Safety, Efficacy and Tolerability of BAF312

August 17, 2023

< 1

Safety, Efficacy and Tolerability of BAF312 in Patients with Stroke due to Intracerebral Hemorrhage

A double blind, randomized, placebo-controlled phase II trial for Novartis (siponimod) in patients with intracerebral hemorrhage

Project Type: Research

Year started: 2021

Diagnosis: Stroke

Association between Peak Flow Measurements and Successful Decannulation This study aims at...

Clinical Comparison of Body-Weight Supported Standard and Balance-Perturbation Training Regimens...

StATins Use In intRacerebral Hemorrhage PatieNts (SATURN): A StrokeNet Study To determine the...